WA
REGN icon

Wealth Alliance’s Regeneron Pharmaceuticals REGN Stock Holding History

Wealth Alliance’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$375K Buy
485
+25
+5% +$19.1K 0.04% 368
2025
Q4 		$355K Hold
460
– – 0.03% 391
2025
Q3 		$259K Buy
460
+51
+12% +$28.8K 0.03% 466
2025
Q2 		$215K Hold
409
– – 0.02% 504
2025
Q1 		$259K Sell
409
-48
-11% -$33K 0.03% 433
2024
Q4 		$326K Sell
457
-104
-19% -$87.3K 0.04% 363
2024
Q3 		$590K Sell
561
-10
-2% -$11.1K 0.07% 239
2024
Q2 		$600K Sell
571
-13
-2% -$12.6K 0.08% 228
2024
Q1 		$562K Sell
584
-29
-5% -$27.6K 0.07% 247
2023
Q4 		$538K Sell
613
-26
-4% -$21.4K 0.08% 239
2023
Q3 		$525K Sell
639
-16
-2% -$12.6K 0.08% 233
2023
Q2 		$471K Sell
655
-37
-5% -$28.5K 0.07% 259
2023
Q1 		$569K Sell
692
-21
-3% -$15.8K 0.09% 221
2022
Q4 		$514K Buy
713
+67
+10% +$49.4K 0.09% 234
2022
Q3 		$445K Buy
646
+92
+17% +$57.9K 0.09% 235
2022
Q2 		$327K Buy
+554
New +$360K 0.06% 299
2021
Q1 		– Sell
-473
Closed -$229K – 405
2020
Q4 		$229K Buy
473
+23
+5% +$12.4K 0.07% 340
2020
Q3 		$252K Buy
450
+22
+5% +$13.3K 0.09% 273
2020
Q2 		$267K Buy
+428
New +$243K 0.11% 240

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wealth Alliance's REGN Position: Q1 2026 in Review

Wealth Alliance increased its Regeneron Pharmaceuticals (REGN) stake by 5.4% in Q1 2026, buying an estimated $19.1K and bringing the position to 485 shares worth $375K. The position accounts for 0.04% of the portfolio, ranked #368.

Wealth Alliance first reported a position in REGN in Q2 2020 and has held it in 19 quarters since. The position peaked at $600K in Q2 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Wealth Alliance held 485 shares of Regeneron Pharmaceuticals worth $375K as of Q1 2026.
  • Wealth Alliance bought 25 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $19.1K.
  • Regeneron Pharmaceuticals made up 0.04% of Wealth Alliance's portfolio in Q1 2026, its #368 holding.
  • Wealth Alliance first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 19 quarters since.
  • Wealth Alliance's Regeneron Pharmaceuticals position peaked at $600K in Q2 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Wealth Alliance's 13F filing for Q1 2026, filed 14 May 2026.